长端粒长度和遗传变异在获得的儿科无形成性贫血:在韩国患者的流鱼研究
Yuna Hong1,2, Jong-Mi Lee1,3, Chaeyeon Lee1,2
1Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
儿科无形成性贫血 (AA) 患者的端粒比健康儿童短. 较长的端粒与免疫抑制疗法中更好的结果相关,突出显示端粒长度是关键生物标志物.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 无形性贫血 (AA) 是一种罕见的骨髓衰竭综合征.
- 短端粒长度是AA的特征,与治疗反应有关.
- 儿科AA需要对端粒动力学和遗传因素进行调查.
研究的目的:
- 使用Flow-FISH测量韩国儿科AA患者的端粒长度.
- 探索端粒缩短与疾病特征,遗传条件和患者结果之间的关系.
- 验证Flow-FISH作为AA中测量端粒长度的可靠方法.
主要方法:
- 分析了来自75名AA患者和101名健康对照者的外周血液样本.
- 端粒长度使用现场流杂交 (Flow-FISH) 量化.
- 遗传评估包括型,染色体破裂测试和临床外体序列 (CES) 遗传骨髓衰竭综合征 (IBMFS) 相关变体.
主要成果:
- 与年龄相匹配的健康对照组相比,AA患者的端粒长度显着较低.
- 接受免疫抑制治疗的患者表现出更长端粒 (高三角 RTL) 的趋势.
- 遗传异常和与IBMFS相关的变异与显著缩短端粒长度有关.
结论:
- 端粒长度是获得的无塑性贫血的一个有效的生物标志物.
- Flow-FISH是一种可靠的方法来测量AA中的端粒长度.
- 较短的端粒与AA病理生理学有关,而较长的端粒预测了免疫抑制疗法的更好的结果.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:23Author Spotlight: Optimization of Performance Parameters of the TAGGG Telomere Length Assay
Published on: April 21, 2023
相关概念视频
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Incomplete Dominance
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
